MTPA gets FDA nod for oral formulation of edaravone to treat ALS

By NS Healthcare Staff Writer

16 May 22

Radicava ORS comes in a small, 5mL dose, with portable bottle, oral dosing syringe, and eliminates the need…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Japan’s Taiho Pharmaceutical agrees to acquire Cullinan Pearl

By NS Healthcare Staff Writer

13 May 22

The transaction also includes a strategic partnership to jointly develop and market Cullinan Oncology’s lead programme, CLN-081/TAS6417, an…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Pfizer to acquire Biohaven Pharmaceuticals in $11.6bn deal

By NS Healthcare Staff Writer

11 May 22

The proposed deal includes the acquisition of Biohaven’s calcitonin gene-related peptide (CGRP) programme, including rimegepant, zavegepant and a…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Pfizer and BioNTech seek FDA EUA for Comirnaty booster in children aged five to 11 years

By NS Healthcare Staff Writer

27 Apr 22

The regulatory submission of Pfizer and BioNTech is based on data from the Phase 2/3 clinical study of…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Astellas extends partnership with University of Tokyo to develop new therapies

By NS Healthcare Staff Writer

26 Apr 22

In the second phase of the alliance, the university will expand its collaboration involvement to include all of…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Pfizer recalls hypertension drug Accupril due to nitrosamine impurities

By NS Healthcare Staff Writer

25 Apr 22

Accupril is an ACE inhibitor used to treat high blood pressure (hypertension), in addition to management of heart…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Samsung Biologics completes acquisition of Samsung Bioepis for $2.3bn

By NS Healthcare Staff Writer

21 Apr 22

The acquisition is said to enhance Samsung Bioepis’ business operations, advance its sales growth, improve operating margin, and…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Regeneron to buy cancer therapeutics company Checkmate for $250m

By NS Healthcare Staff Writer

20 Apr 22

With the acquisition, Regeneron will obtain Checkmate’s lead candidate vidutolimod, an investigational, advanced generation CpG-A oligodeoxynucleotide Toll-like receptor…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Halozyme to buy speciality pharmaceutical firm Antares Pharma for $960m

By NS Healthcare Staff Writer

14 Apr 22

Antares’ commercial products and the current autoinjector expertise will help accelerate Halozyme’s approach to drive durable revenue growth…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

GSK agrees to buy Sierra Oncology for $1.9bn

By NS Healthcare Staff Writer

14 Apr 22

The proposed acquisition is in line with GSK’s plans to build a strong portfolio of new speciality medicines…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates